[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Aether Tech S.L.\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":46},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":28,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100589315","validation-study-of-the-emily-ai-device-in-acute-and-chronic-respiratory-failure-100589315",false,"NCT06952816","Validation Study of the EMILY AI Device in Acute and Chronic Respiratory Failure","Functional, Clinical, and Predictive Validation Study of the EMILY AI Device in Patients With Acute and Chronic Respiratory Failure","Inclusion Criteria:\n\n* Men and women over 18 years of age.\n* Admitted to intermediate respiratory care unit with a diagnosis of acute respiratory failure for at least 8 hours.\n* Informed consent understood and signed.\n\nExclusion Criteria:\n\n* Hemodynamic instability.\n* Severe temperature changes.\n* Hemoglobinopathies, severe anemia, severe acidosis, or severe alkalosis.\n* Anatomical disturbances.\n* Pregnancy or breastfeeding.","ALL","18 Years",{"count":19,"type":20},20,"ESTIMATED","INTERVENTIONAL",[23],"NA","Currently, there is no holistic solution for patients with respiratory diseases that includes oxygenation and management of a patient with respiratory disease, combining dynamic and automatic O2 administration and the detection of clinical worsening, generating a diagnostic suspicion, a management proposal, and notifying the medical team.\n\nFor device validation, prospective studies will be conducted in patients in respiratory intermediate care units, conventional hospitalization, during physical activity in the hospital setting, and in an out-of-hospital setting. The device will be evaluated in terms of oxygenation efficacy, response time, patient safety, efficiency, versatility, clinical benefit, and adaptability.",[26,27],"Chronic Respiratory Failure","Acute Respiratory Failure",[29,30,31,32],"Respiratory failure","Hypoxia","Hyperxia","Oxigenotherapy","RECRUITING","2026-01-08",{"date":36,"type":37},"2026-01-09","ACTUAL",{"date":39,"type":37},"2025-04-23",{"date":41,"type":20},"2026-12-30",{"name":43,"class":44},"Aether Tech S.L.","INDUSTRY",2,""]